IMAT - ultrafast tomography for coronary artery disease Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steven Durrington who wrote (2374)	4/13/1998 1:09:00 AM
From: Robert Sherman	Read Replies (3) of 3725

Durro, I have always believed that IMAT machines are more suited for overseas market, especially asis, europe, australia. If I am not mistaken heart desease is the number one killer in asia, and other regions of the world. You are correct as far as greedy insurance companies and greedy doctors are concerned in the US. The HMO are only interested in providing the least amount of medical treatment that they can get away with. However, once the technology is proven and the general public is made aware of the benefits, the acceptance of the technology will be swift. That is when IMAT will be a $20 stock and will probably get bought by a bigger player. Anyway, that is what I am hoping for. I am a believer in IMAT's technology. -Robert.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next